• Profile
Close

TERT promoter hypermethylation in gastrointestinal cancer: A potential stool biomarker

The Oncologist Aug 11, 2017

Liu L, et al. – This study was meant to gauge telomerase reverse transcriptase gene (TERT) promoter methylation in fecal samples from gastrointestinal cancer (GIC) patients and healthy adults, and its value as a stool biomarker for GIC detection was examined. In view of the outcomes, stool TERT promoter methylation was feasible as an additional tool in noninvasive GIC screening.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay